Last reviewed · How we verify

NCT04239898

Microgreen Consumption for Healthy Aging

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Red cabbage microgreens in Aging in 26 participants. Completed in 30 November 2019.

Timeline
16 July 2019
Primary endpoint
22 November 2019
30 November 2019

Quick facts

Lead sponsorColorado State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposebasic science
Enrollment26
Start date16 July 2019
Primary completion22 November 2019
Estimated completion30 November 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Colorado State University

Who can join

Adults 45 to 70, any sex, with Aging or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Microgreens are an emerging horticultural food crop with potential to improve human health. Previous research suggests they have broad consumer acceptance and that the micronutrient and bioactive compound levels are higher than that of their mature counterparts. To date, no studies have explored the feasibility of microgreen consumption, gastrointestinal tolerance of microgreen consumption, or their potential health impacts in humans. Therefore, the overall goal of this study is to explore the feasibility and acceptability of daily microgreen consumption, gastrointestinal tolerability, and potential health impacts of red cabbage and red beet microgreens in healthy middle-aged/older men and postmenopausal women - a population inherently at risk for chronic disease, e.g. cardiovascular disease.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Sulforaphane Bioavailability in Healthy Subjects Fed a Single Serving of Fresh Broccoli Microgreens.
    Bouranis JA, Wong CP, Beaver LM, Uesugi SL, et al · · 2023 · cited 6× · PMID 37893677 · DOI 10.3390/foods12203784
  2. Feasibility and Tolerability of Daily Microgreen Consumption in Healthy Middle-Aged/Older Adults: A Randomized, Open-Label, Controlled Crossover Trial.
    Lee SY, Michell KA, Butler MM, Smith BT, et al · · 2025 · cited 1× · PMID 39940327 · DOI 10.3390/nu17030467

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Colorado State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04239898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing